Clinical trial
Left Atrial Appendage Closure During Cardiac Surgery in Atrial Fibrillation Patients With Seralene
NCT07360899 is registered in ClinicalTrials.gov with Institute of Cardiovascular Diseases, Vojvodina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Left Atrial Appendage Closure During Cardiac Surgery in Atrial Fibrillation Patients With Seralene
- Lead sponsor
- Institute of Cardiovascular Diseases, Vojvodina
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 1, 2025
- Completion date
- June 30, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulant therapy, atrial appendage closure for atrial fibrillation, atrial fibrillation (af), mitral valve surgery, stroke (in patients with atrial fibrillation)